At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMZ DEFIANCE DAILY TARGET 2X LONG HIMS ETF
Market Closed 10-30 16:00:00 EDT
22.31
-3.54
-13.69%
盘后22.83
+0.52+2.33%
19:59 EDT
High23.94Low20.61Vol358.88K
Open23.66D1 Closing25.85Amplitude12.90%
Mkt Cap53.09MTradable Cap53.09MTotal Shares2.38M
T/O8.01MT/O Rate15.08%Tradable Shares2.38M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

24H | Nasdaq Futures Fall 1.5%; Micron Slides 3%; Coinbase Sinks 5%; Amazon, AMD Drop over 6%; Reddit Plunges 18%; Intel Tumbles 23%
US Overnight  ·  10-30 08:14
24H | Nasdaq Futures Fall 1.5%; Micron Slides 3%; Coinbase Sinks 5%; Amazon, AMD Drop over 6%; Reddit Plunges 18%; Intel Tumbles 23%
Hims & Hers Climbs on Potential to Sell Some Unapproved Peptides
Reuters  ·  10-29
Hims & Hers Climbs on Potential to Sell Some Unapproved Peptides
The U.S. Government Will no Longer Penalize American Companies for Making Six Popular Peptides
Dow Jones  ·  10-29
The U.S. Government Will no Longer Penalize American Companies for Making Six Popular Peptides
US Health Secretary Kennedy Opens Access to Some Unapproved Peptides
Reuters  ·  10-28
US Health Secretary Kennedy Opens Access to Some Unapproved Peptides
Moderately bullish activity in Hims and Hers Health with shares up 2.23%
TIPRANKS  ·  10-28
Moderately bullish activity in Hims and Hers Health with shares up 2.23%
Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?
Bellwether Stocks Movement  ·  10-24
Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?
Hims & Hers Slips Ahead of White House Meeting on Peptide Policy
Reuters  ·  10-23
Hims & Hers Slips Ahead of White House Meeting on Peptide Policy
Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint
MT Newswires Live  ·  10-23
Market Chatter: Hims & Hers Health Bids Judge to Toss Federal Trade Commission Complaint
Hims & Hers Health Shares Slid Even Though Sales Rose
Simply Wall St.  ·  10-23
Hims & Hers Health Shares Slid Even Though Sales Rose
Hims & Hers Health Expands Testosterone Care with Injectable and Oral TRT
Reuters  ·  10-21
Hims & Hers Health Expands Testosterone Care with Injectable and Oral TRT
Hims & Hers Health Inc: Hims Expands Testosterone Care with Injectable and Oral Trt
THOMSON REUTERS  ·  10-21
Hims & Hers Health Inc: Hims Expands Testosterone Care with Injectable and Oral Trt
Hims & Hers Health - Testosterone Offering Scaling Rapidly as of Q2 2026
THOMSON REUTERS  ·  10-21
Hims & Hers Health - Testosterone Offering Scaling Rapidly as of Q2 2026
Hims & Hers Health - Provides Three New Testosterone Treatment Options Starting Today
THOMSON REUTERS  ·  10-21
Hims & Hers Health - Provides Three New Testosterone Treatment Options Starting Today
Hims & Hers Health - Launches Twice-Weekly Subcutaneous Injection for Testosterone Increase
THOMSON REUTERS  ·  10-21
Hims & Hers Health - Launches Twice-Weekly Subcutaneous Injection for Testosterone Increase
Moderately bullish activity in Hims and Hers Health with shares up 4.33%
TIPRANKS  ·  10-20
Moderately bullish activity in Hims and Hers Health with shares up 4.33%
Hims & Hers Health Inc: Introducing Hims in Germany
THOMSON REUTERS  ·  10-20
Hims & Hers Health Inc: Introducing Hims in Germany
Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 0.32%
TIPRANKS  ·  10-20
Cboe data shows mixed options sentiment in Hims and Hers Health with shares up 0.32%
Is Peptide Compounding Review Altering The Investment Case For Hims Shares (HIMS)?
Simply Wall St.  ·  10-17
Is Peptide Compounding Review Altering The Investment Case For Hims Shares (HIMS)?
From $29 To Over $200: Has Moderna Become Dangerously Overvalued?
Bellwether Stocks Movement  ·  10-17
From $29 To Over $200: Has Moderna Become Dangerously Overvalued?
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Hims & Hers Health (HIMS)
TIPRANKS  ·  10-16
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Hims & Hers Health (HIMS)

Introduction

Company Name.
DEFIANCE DAILY TARGET 2X LONG HIMS ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--